Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Metabolism of gammalinolenic acid in human neutrophilsChilton-Lopez, M E Surette, D D Swan, et al.Biochimica Et Biophysica Acta|May 13, 1987
Human neutrophils incorporate arachidonic acid and saturated fatty acids into separate molecular species of phospholipidsC L Swendsen, F H Chilton, J T O'Flaherty, et al.The Journal of Nutrition|August 1, 1997
Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humansM M Johnson, D D Swan, M E Surette, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|August 29, 2001
Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cellsC E Clay, A M Namen, G Atsumi, et al.The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Inhibitors of coenzyme A-independent transacylase induce apoptosis in human HL-60 cellsJ D Winkler, T Eris, C M Sung, et al.Prostaglandins|January 1, 1992
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cellsR E Whatley, K L Clay, F H Chilton, et al.American Journal of Respiratory and Critical Care Medicine|March 1, 1994
Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholineM H Shin, F J Averill, W C Hubbard, et al.The Journal of Biological Chemistry|May 25, 1982
Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholineF H Chilton, J T O'Flaherty, C E Walsh, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2001
Enhancement of mast cell survival: a novel function of some secretory phospholipase A(2) isotypesA N Fonteh, C R Marion, B J Barham, et al.Molecular Pharmacology|March 14, 1998
Beta-lactams SB 212047 and SB 216754 are irreversible, time-dependent inhibitors of coenzyme A-independent transacylaseJ D Winkler, C M Sung, M Chabot-Flecher, et al.Pageof 8